256 related articles for article (PubMed ID: 17063150)
41. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder.
Mazei-Robison MS; Couch RS; Shelton RC; Stein MA; Blakely RD
Neuropharmacology; 2005 Nov; 49(6):724-36. PubMed ID: 16171832
[TBL] [Abstract][Full Text] [Related]
42. Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study.
Wolff C; Alfred A; Lindermüller A; Rettig K; Mattejat F; Gerwe M; Slawik L; Schäuble B
Curr Med Res Opin; 2011; 27 Suppl 2():35-44. PubMed ID: 21787126
[TBL] [Abstract][Full Text] [Related]
43. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
[TBL] [Abstract][Full Text] [Related]
44. Dopamine transporter gene moderates response to behavioral parent training in children with ADHD: a pilot study.
van den Hoofdakker BJ; Nauta MH; Dijck-Brouwer DA; van der Veen-Mulders L; Sytema S; Emmelkamp PM; Minderaa RB; Hoekstra PJ
Dev Psychol; 2012 Mar; 48(2):567-74. PubMed ID: 22182296
[TBL] [Abstract][Full Text] [Related]
45. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.
Roman T; Szobot C; Martins S; Biederman J; Rohde LA; Hutz MH
Pharmacogenetics; 2002 Aug; 12(6):497-9. PubMed ID: 12172219
[TBL] [Abstract][Full Text] [Related]
46. Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD.
Karama S; Grizenko N; Sonuga-Barke E; Doyle A; Biederman J; Mbekou V; Polotskaia A; Ter-Stepanian M; De Guzman R; Bellingham J; Sengupta S; Joober R
BMC Psychiatry; 2008 Jun; 8():45. PubMed ID: 18559107
[TBL] [Abstract][Full Text] [Related]
47. Association Between 5-HTTLPR Polymorphism and Tics after Treatment with Methylphenidate in Korean Children with Attention-Deficit/Hyperactivity Disorder.
Park SY; Kim EJ; Cheon KA
J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):633-40. PubMed ID: 26402385
[TBL] [Abstract][Full Text] [Related]
48. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
[TBL] [Abstract][Full Text] [Related]
49. Crack cocaine users show differences in genotype frequencies of the 3' UTR variable number of tandem repeats of the dopamine transporter gene (DAT1/SLC6A3).
Stolf AR; Szobot CM; Halpern R; Akutagava-Martins GC; Müller D; Guimaraes LS; Kessler FH; Pechansky F; Roman T
Neuropsychobiology; 2014; 70(1):44-51. PubMed ID: 25247548
[TBL] [Abstract][Full Text] [Related]
50. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.
de Azeredo LA; Rovaris DL; Mota NR; Polina ER; Marques FZ; Contini V; Vitola ES; Belmonte-de-Abreu P; Rohde LA; Grevet EH; Bau CH
Eur Arch Psychiatry Clin Neurosci; 2014 Aug; 264(5):401-8. PubMed ID: 24487615
[TBL] [Abstract][Full Text] [Related]
51. Association of the GRIN2B rs2284411 polymorphism with methylphenidate response in attention-deficit/hyperactivity disorder.
Kim JI; Kim JW; Park JE; Park S; Hong SB; Han DH; Cheong JH; Choi JW; Lee S; Kim BN
J Psychopharmacol; 2017 Aug; 31(8):1070-1077. PubMed ID: 27624150
[TBL] [Abstract][Full Text] [Related]
52. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
[TBL] [Abstract][Full Text] [Related]
53. Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.
Lee SH; Kim SW; Lee MG; Yook KH; Greenhill LL; Fradin KN; Hong HJ
Psychiatry Res; 2011 Apr; 186(2-3):338-44. PubMed ID: 20863575
[TBL] [Abstract][Full Text] [Related]
54. Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.
Cho SC; Kim BN; Cummins TD; Kim JW; Bellgrove MA
J Psychopharmacol; 2012 Mar; 26(3):380-9. PubMed ID: 21628343
[TBL] [Abstract][Full Text] [Related]
55. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
[TBL] [Abstract][Full Text] [Related]
56. Catechol-O-methyltransferase valine158methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention-deficit/hyperactivity disorder.
Salatino-Oliveira A; Genro JP; Zeni C; Polanczyk GV; Chazan R; Guimarães AP; Callegari-Jacques SM; Rohde LA; Hutz MH
Biol Psychiatry; 2011 Aug; 70(3):216-21. PubMed ID: 21550019
[TBL] [Abstract][Full Text] [Related]
57. Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.
Kim BN; Kim JW; Hong SB; Cho SC; Shin MS; Yoo HJ
Behav Brain Funct; 2010 Oct; 6():57. PubMed ID: 20929549
[TBL] [Abstract][Full Text] [Related]
58. DRD3 Gene and ADHD: A Pharmaco-Behavioural Genetic Study.
Fageera W; Sengupta SM; Labbe A; Grizenko N; Joober R
Neuromolecular Med; 2018 Dec; 20(4):515-524. PubMed ID: 30051166
[TBL] [Abstract][Full Text] [Related]
59.
Fageera W; Grizenko N; Sengupta SM; Schmitz N; Joober R
J Atten Disord; 2021 Oct; 25(12):1720-1730. PubMed ID: 32564645
[TBL] [Abstract][Full Text] [Related]
60. Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).
Purper-Ouakil D; Wohl M; Orejarena S; Cortese S; Boni C; Asch M; Mouren MC; Gorwood P
Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1425-30. PubMed ID: 18563707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
